Acquisition by Perry Traquina of 3167 shares of Morgan Stanley subject to Rule 16b-3
| BTK Index | 5,688 30.71 0.54% |
About 61% of ARCA Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding ARCA Biotechnology suggests that many traders are alarmed. The current market sentiment, together with ARCA Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use ARCA Biotechnology index news signals to limit their universe of possible portfolio assets.
ARCA Biotechnology index news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ARCA daily returns and investor perception about the current price of ARCA Biotechnology as well as its diversification or hedging effects on your existing portfolios.
Filed transaction by Morgan Stanley Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at fool.com
 |
ARCA Biotechnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ARCA Biotechnology index to make a market-neutral strategy. Peer analysis of ARCA Biotechnology could also be used in its relative valuation, which is a method of valuing ARCA Biotechnology by comparing valuation metrics with similar companies.
Peers
ARCA Biotechnology Related Equities
| FDUS | Fidus Investment | 1.81 | ||||
| RCC | Small Cap | 1.63 | ||||
| SEIC | SEI Investments | 0.88 | ||||
| FRHC | Freedom Holding | 0.85 | ||||
| MS | Morgan Stanley | 0.45 | ||||
| EQIX | Equinix | 0.52 | ||||
| MNTK | Montauk Renewables | 1.60 |